Attorney General Eric T. Schneiderman’s office has filed a lawsuit against Insys Therapeutics, Inc., a company that sells a highly addictive fentanyl drug called Subsys. Although Subsys was approved by the Food and Drug Administration (FDA) to treat cancer-related breakthrough pain the complaint alleges that Insys recklessly marketed the drug for much wider use, covering a much broader set of patients. The suit claims Insys downplayed addiction risks and bribed doctor to prescribe Subsys. Schneiderman’s office wants Insys to surrender all revenues accumulated during the period of misconduct-up to $75 million.